欧州連合 - スウェーデン語 - EMA (European Medicines Agency)

bausch health ireland limited - metylnaltrexonbromid - opioid-related disorders; constipation - perifera opioid receptor antagonister - behandling av opioidinducerad förstoppning hos patienter med avancerad sjukdom som får palliativ vård vid svar på vanlig laxerande behandling har inte varit tillräcklig.

欧州連合 - スウェーデン語 - EMA (European Medicines Agency)

akcea therapeutics ireland limited - volanesorsen natrium - hyperlipoproteinemi typ i - andra lipidmodifierande medel - waylivra är indicerat som komplement till kosten hos vuxna patienter med genetiskt bekräftat familjär chylomicronemia syndrom (fcs) och hög risk för pankreatit, i vilken respons till kost och triglycerider sänka behandling har varit otillräckligt.

欧州連合 - スウェーデン語 - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - ambrisentan - hypertoni, lungformig - antihypertensiva medel, - volibris is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii to iii, including use in combination treatment (see section 5.  efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease. volibris is indicated for treatment of pah in adolescents and children (aged 8 to less than 18 years) of who functional class (fc) ii to iii including use in combination treatment. efficacy has been shown in ipah, familial, corrected congenital and in pah associated with connective tissue disease (see section 5.

スウェーデン - スウェーデン語 - Läkemedelsverket (Medical Products Agency)

eli lilly sweden ab - insulin, humant, isofan - injektionsvätska, suspension i förfylld injektionspenna - 100 ie/ml - glycerol hjälpämne; insulin, humant, isofan 100 ie aktiv substans - insulin (humant)

スウェーデン - スウェーデン語 - Läkemedelsverket (Medical Products Agency)

eli lilly sweden ab - somatropin - pulver och vätska till injektionsvätska, lösning - 12 mg - somatropin 12 mg aktiv substans; mannitol hjälpämne; glycerol hjälpämne - somatropin

スウェーデン - スウェーデン語 - Läkemedelsverket (Medical Products Agency)

eli lilly sweden ab - somatropin - pulver och vätska till injektionsvätska, lösning - 24 mg - glycerol hjälpämne; somatropin 24 mg aktiv substans; mannitol hjälpämne - somatropin

スウェーデン - スウェーデン語 - Läkemedelsverket (Medical Products Agency)

eli lilly sweden ab - somatropin - pulver och vätska till injektionsvätska, lösning - 6 mg - glycerol hjälpämne; mannitol hjälpämne; somatropin 6 mg aktiv substans - somatropin

欧州連合 - スウェーデン語 - EMA (European Medicines Agency)

viatris healthcare limited - imiquimod - condylomata acuminata; keratosis; keratosis, actinic; carcinoma, basal cell - antibiotika och kemoterapeutiska medel för dermatologisk användning - imiquimod cream is indicated for the topical treatment of :external genital and perianal warts (condylomata acuminata) in adults. small superficial basal cell carcinomas (sbccs) in adults. clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses (aks) on the face or scalp in immunocompetent adult patients when size or number of lesions limit the efficacy and/or acceptability of cryotherapy and other topical treatment options are contraindicated or less appropriate.

欧州連合 - スウェーデン語 - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - umeclidinium bromid, vilanterol trifenatate - pulmonell sjukdom, kronisk obstruktiv - läkemedel mot obstruktiv lungsjukdom, - anoro ellipta anges som ett underhåll bronkdilaterande behandling för att lindra symtom hos vuxna patienter med kronisk obstruktiv lungsjukdom (kol).

欧州連合 - スウェーデン語 - EMA (European Medicines Agency)

taw pharma (ireland) limited - klopidogrelhydroklorid - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antitrombotiska medel - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:,    - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). ,     - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event.  , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.